Loring Wolcott & Coolidge Fiduciary Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
BFIM
HNB
Loring Wolcott & Coolidge Fiduciary Advisors's DBD Position: Q2 2023 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 6,500 shares — an estimated $7.8K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in DBD in Q3 2017 and held it in 10 quarters. The position peaked at $83K in Q2 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 6,500 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $7.8K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Diebold Nixdorf Incorporated in Q3 2017 and held it in 10 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Diebold Nixdorf Incorporated position peaked at $83K in Q2 2021.
- 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.